Literature DB >> 27236159

 An autoimmune polyglandular syndrome complicated with celiac disease and autoimmune hepatitis.

Romina Dieli-Crimi1, Concepción Núñez1, Lourdes Estrada2, Natalia López-Palacios3.   

Abstract

Autoimmune polyglandular syndrome (APS) is a combination of different autoimmune diseases. The close relationship between immune-mediated disorders makes it mandatory to perform serological screening periodically in order to avoid delayed diagnosis of additional autoimmune diseases. We studied a patient with type 1 diabetes (T1D) who later developed an autoimmune thyroid disease (ATD) and was referred to our hospital with a serious condition of his clinical status. The patient was suffering from an advance stage of celiac disease (CD), the delay in its diagnosis and in the establishment of a gluten-free dietled the patient to a severe proteincalorie malnutrition. Later, the patient developed an autoimmune hepatitis (AIH). We consider that clinical deterioration in patients with APS should alert physicians about the possible presence of other immune-mediated diseases. Periodic screening for autoantibodies would help to prevent delayed diagnosis and would improve patient's quality of life.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27236159

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  3 in total

Review 1.  To screen or not to screen? Celiac antibodies in liver diseases.

Authors:  Janaína Luz Narciso-Schiavon; Leonardo Lucca Schiavon
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

Review 2.  Diplopia in a patient with Hashimoto's thyroiditis: A case report and literature review.

Authors:  Chengqun Ju; Linna Zhang
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

3.  Induction of remission in autoimmune polyglandular syndrome type three (APS III): An old drug with new perspectives.

Authors:  Magdy Mohamed Allam; Hanaa Tarek Hussein Elzawawy
Journal:  Clin Case Rep       Date:  2018-10-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.